CD248 and non-small cell lung carcinoma: In our pervious study, we demonstrated that CD248 is ubiquitous within CAFs from NSCLC tissues, and its expression is intricately linked to worse outcome and clinicopathological profiles, namely, NSCLC‐related tumour‐node metastasis (TNM) stage, lymphatic metastasis and tumour stage and differentiation.12